Update From the Advisory Committee on Immunization Practices | Zendy

Jennifer E. Schuster | Zendy; Sean T. O’Leary | Zendy; David W. Kimberlin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Update From the Advisory Committee on Immunization Practices

Author(s) -

Jennifer E. Schuster,

Sean T. O’Leary,

David W. Kimberlin

Publication year - 2016

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piw086

Subject(s) - medicine , advisory committee , immunization , vaccination , meningococcal vaccine , pediatrics , family medicine , hepatitis b , hepatitis b vaccine , virology , immunology , hepatitis b virus , virus , antibody , public administration , hbsag , political science

A 9-valent human papillomavirus vaccine is now recommended as a 2-dose series (0, 6-12 months) for healthy adolescents 9-14 years. Meningococcal type B (MenB)-FHbp (Trumenba), previously a 3-dose series, may be given in a 2-dose series (0, 6 months) to healthy adolescents; MenB vaccination remains a Category B recommendation (individual clinical decision making) for healthy adolescents. The wording for the recommendations for the hepatitis B vaccine birth dose was strengthened to encourage administration of the birth dose by 24 hours of age.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research